# Tumor-Targeted-NIR-II Fluorescent Molecular Probes for the Identification of Breast Cancer Tissue and SLN Metastatic Status

> **NCT06713161** · — · RECRUITING · sponsor: **Yunnan Cancer Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Breast Cancer
- Sentinel Lymph Node
- Metastases
- Margin Assessment

## Interventions

- **DIAGNOSTIC_TEST:** NIR-II Probe(i.e ICG-POL6326) incubation solution

## Key facts

- **NCT ID:** NCT06713161
- **Lead sponsor:** Yunnan Cancer Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-01
- **Primary completion:** 2025-08-25
- **Final completion:** 2025-12-25
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2024-12-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06713161

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06713161, "Tumor-Targeted-NIR-II Fluorescent Molecular Probes for the Identification of Breast Cancer Tissue and SLN Metastatic Status". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06713161. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*